Kimberly Stegmaier

Broad Institute

Full Professor(heuristic)

Protein Degradation and Inhibitors · Molecular Biology

Compare more Molecular Biology professors.

h-index65
i10-index147
Publications774
Citations22,654

Grants

12 total · 4 active

NIH #R35CA283977

Targeting Pediatric Cancer Vulnerabilities

Active
Amount
$1M–$2M
Period
2023-09-19 → 2030-08-31
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #P01CA217959

Targeting neuroblastoma cell state plasticity

Active
Amount
$600K–$700K
Period
2017-09-18 → 2029-02-28
PIs
1

Awarded at CHILDREN'S HOSP OF PHILADELPHIA

NIH #U01CA281840

Immunotherapeutic targeting of gangliosides in Ewing Sarcoma

Active
Amount
$700K–$800K
Period
2023-09-19 → 2028-08-31
PIs
2

Awarded at DANA-FARBER CANCER INST

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

12 total · 4 active

NIH #R35CA283977

Targeting Pediatric Cancer Vulnerabilities

Active
Amount
$1M–$2M
Period
2023-09-19 → 2030-08-31
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #P01CA217959

Targeting neuroblastoma cell state plasticity

Active
Amount
$600K–$700K
Period
2017-09-18 → 2029-02-28
PIs
1

Awarded at CHILDREN'S HOSP OF PHILADELPHIA

NIH #U01CA281840

Immunotherapeutic targeting of gangliosides in Ewing Sarcoma

Active
Amount
$700K–$800K
Period
2023-09-19 → 2028-08-31
PIs
2

Awarded at DANA-FARBER CANCER INST

NIH #R01CA283395

Mechanisms of Toxicity Induced by EWS/FLI1 Overdose in Ewing Sarcoma

Active
Amount
$700K–$800K
Period
2023-06-07 → 2028-05-31
PIs
2

Awarded at DANA-FARBER CANCER INST

NIH #OT2CA297572

PROTECT (Harnessing PROTEin degradation for Advanced Childhood Tumors)

Amount
$1M–$2M
Period
2024-05-01 → 2026-04-30
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #U54CA231637

The Center for Therapeutic Targeting of EWS-oncoproteins

Amount
$12M–$13M
Period
2018-09-10 → 2024-06-30
PIs
2

Awarded at DANA-FARBER CANCER INST

NIH #R35CA210030

Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer

Amount
$1M–$2M
Period
2016-08-09 → 2023-07-31
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #R01CA204915

Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics

Amount
$400K–$500K
Period
2017-01-01 → 2022-06-30
PIs
2

Awarded at DANA-FARBER CANCER INST

NIH #R01NS088355

Targeting BET-bromodomains in neuroblastoma

Amount
$600K–$700K
Period
2015-05-15 → 2020-03-31
PIs
2

Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

NIH #R01CA140292

Validating Syk as a Target for AML Therapy

Amount
$300K–$400K
Period
2009-07-07 → 2019-07-31
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #P50CA206963

Targeting SYK Kinase in AML

Amount
$300K–$400K
Period
— → 2019-03-31
PIs
1

Awarded at BRIGHAM AND WOMEN'S HOSPITAL

NIH #R03DA034596

Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing's Sarcoma

Amount
<$100K
Period
2012-05-01 → 2014-04-30
PIs
2

Awarded at DANA-FARBER CANCER INST

Recent Public Signals

  1. New paper: USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in KMT2Ar acute leukemia (Blood)2026-07-08
  2. New NIH award: Targeting Pediatric Cancer Vulnerabilities2023-09-19
  3. New NIH award: Immunotherapeutic targeting of gangliosides in Ewing Sarcoma2023-09-19

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-14

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-0218-7895

Professor Insights

Career Trajectory